Last reviewed · How we verify

NCT02542488

STOPBANG As A Screening Tool for Obstructive Sleep Apnoea in Pregnancy

Completed Last updated 1 February 2019
What this trial tests

trial testing STOPBANG Questionnaire in Obstructive Sleep Apnoea in 117 participants. Completed in 27 March 2018.

Timeline
2 February 2016
Primary endpoint
31 August 2017
27 March 2018

Quick facts

Lead sponsorCity Hospitals Sunderland NHS Foundation Trust
StatusCompleted
Study typeOBSERVATIONAL
Enrollment117
Start date2 February 2016
Primary completion31 August 2017
Estimated completion27 March 2018
Sites1 location across United Kingdom

Drugs / interventions tested

Conditions studied

Sponsor

City Hospitals Sunderland NHS Foundation Trust

Who can join

18 and older, female only, with Obstructive Sleep Apnoea or Pregnancy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study evaluates the use of the STOPBANG questionnaire to predict whether a pregnant woman with class III obesity has obstructive sleep apnoea. All participants will have a STOPBANG score and modified STOPBANG score (substituting Epworth score \> 10 with the tired item) calculated and then be tested with overnight pulse oximetry to see if they meet ODI criteria for obstructive sleep apnoea.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. The STOP-Bang Questionnaire as a Screening Tool for Obstructive Sleep Apnea in Pregnancy.
    Pearson F, Batterham AM, Cope S. · · 2019 · cited 18× · PMID 31053210 · DOI 10.5664/jcsm.7754

Verify or expand the search:

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02542488.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing